ANNX.NASDAQAnnexon, INC

Form 4: Annexon Director Acquires Stock Options

Sentiment:

Statement of Changes in Beneficial Ownership


Director William A. Jones Jr. acquired 65,000 stock options in Annexon, Inc. on June 11, 2026.

Summary

  • William A. Jones Jr., a Director at Annexon, Inc., was granted 65,000 stock options on June 11, 2026.
  • These options have an exercise price of $4.70 and an expiration date of June 11, 2036.
  • The underlying shares vest 100% on the earlier of the first anniversary of June 11, 2026, or the next Annual Meeting, contingent on continued service as a director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation event for a director rather than a significant strategic or financial development for the company.

Positives

  • Director's acquisition of stock options indicates a commitment to the company's future performance.
  • The grant of options aligns the director's interests with those of shareholders.
  • The exercise price of $4.70 suggests a potential for significant upside if the stock price increases.

Negatives

  • The filing does not provide details on the rationale behind the option grant beyond standard compensation practices.
  • The vesting schedule is contingent on continued service, which introduces an element of uncertainty for the director.

Risks

  • The value of the stock options is directly tied to the future performance of Annexon, Inc.'s stock price.
  • If the company's stock price does not exceed the exercise price of $4.70, the options may expire worthless.
  • The vesting is subject to the reporting person's continuous service, meaning any departure before vesting would forfeit the options.

Future Outlook

The vesting of the stock options is contingent on the reporting person's continuous service as a director, with full vesting occurring on the earlier of the first anniversary of June 11, 2026, or the next Annual Meeting following June 11, 2026.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, aiming to incentivize long-term performance and align executive interests with shareholder value. Annexon, Inc. operates in this space, making this type of compensation a standard element of corporate governance.

Stakeholder Impact

  • Shareholders: The grant of options to a director is a standard compensation practice. Its impact on shareholders depends on the company's future stock performance and the director's continued contribution.
  • Employees: This filing does not directly impact employees, but it reflects the company's compensation structure for its board members.
  • Management: The options incentivize the director to perform effectively and contribute to the company's success.

Next Steps

  • William A. Jones Jr. must remain in continuous service as a director until the vesting date of the stock options.
  • The stock options will become exercisable on the vesting date, allowing the director to purchase Annexon, Inc. common stock at $4.70 per share.

Key Dates

DateDescription
06/11/2026Earliest transaction date and date stock options were granted.
06/15/2026Date the statement was signed.
06/11/2036Expiration date of the stock options.

Keywords

Annexon Inc, ANNX, Form 4, Stock Options, Director Compensation, Beneficial Ownership, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.